- Home
- GFR vs MXCT Comparison
GFR vs MXCT Comparison
Compare GFR & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFR
- MXCT
- Stock Information
- Founded
- GFR 2018
- MXCT 1999
- Country
- GFR Canada
- MXCT United States
- Employees
- GFR N/A
- MXCT N/A
- Industry
- GFR
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GFR
- MXCT Health Care
- Exchange
- GFR Nasdaq
- MXCT Nasdaq
- Market Cap
- GFR 485.6M
- MXCT 534.8M
- IPO Year
- GFR N/A
- MXCT 2021
- Fundamental
- Price
- GFR $6.94
- MXCT $5.10
- Analyst Decision
- GFR Buy
- MXCT Strong Buy
- Analyst Count
- GFR 1
- MXCT 2
- Target Price
- GFR $10.50
- MXCT $9.50
- AVG Volume (30 Days)
- GFR 87.3K
- MXCT 565.6K
- Earning Date
- GFR 02-14-2025
- MXCT 03-11-2025
- Dividend Yield
- GFR N/A
- MXCT N/A
- EPS Growth
- GFR N/A
- MXCT N/A
- EPS
- GFR 0.40
- MXCT N/A
- Revenue
- GFR $551,353,492.00
- MXCT $45,599,000.00
- Revenue This Year
- GFR $35.03
- MXCT N/A
- Revenue Next Year
- GFR $37.50
- MXCT $21.13
- P/E Ratio
- GFR $17.18
- MXCT N/A
- Revenue Growth
- GFR 11.20
- MXCT 19.85
- 52 Week Low
- GFR $4.68
- MXCT $3.17
- 52 Week High
- GFR $8.16
- MXCT $5.29
- Technical
- Relative Strength Index (RSI)
- GFR 47.35
- MXCT 68.34
- Support Level
- GFR $6.93
- MXCT $4.64
- Resistance Level
- GFR $7.34
- MXCT $5.09
- Average True Range (ATR)
- GFR 0.21
- MXCT 0.31
- MACD
- GFR -0.00
- MXCT 0.06
- Stochastic Oscillator
- GFR 23.48
- MXCT 91.56
About GFR Greenfire Resources Ltd.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.